Citius Pharmaceuticals, Inc.
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Mar 11, 2026 | D. Boral Capital | maintain | Buy → Buy | — | 34% |
| Dec 4, 2025 | D. Boral Capital | maintain | Buy → Buy | $6 | 34% |
| Aug 13, 2025 | D. Boral Capital | maintain | Buy → Buy | $6 | 34% |
| Jun 30, 2025 | D. Boral Capital | maintain | Buy → Buy | $6 | 34% |
| Jun 10, 2025 | D. Boral Capital | maintain | Buy → Buy | $6 | 34% |
| Jun 9, 2025 | D. Boral Capital | maintain | Buy → Buy | $9 | 34% |
| May 23, 2025 | Maxim Group | downgrade | Buy → Hold | $0 | 42% |
| May 15, 2025 | D. Boral Capital | maintain | Buy → Buy | $9 | 34% |
| Feb 18, 2025 | D. Boral Capital | maintain | Buy → Buy | $9 | 34% |
| Jan 7, 2025 | D. Boral Capital | maintain | Buy → Buy | $9 | 34% |
| Dec 30, 2024 | D. Boral Capital | upgrade | Hold → Buy | $9 | 34% |
| Nov 22, 2024 | D. Boral Capital | downgrade | Buy → Hold | $0 | 34% |
| Nov 12, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $4 | 44% |
| Nov 11, 2024 | D. Boral Capital | maintain | Buy → Buy | $6 | 34% |
| Aug 19, 2024 | EF Hutton | maintain | Buy → Buy | $6 | 30% |
| Aug 8, 2024 | EF Hutton | maintain | Buy → Buy | $6 | 30% |
| Aug 5, 2024 | EF Hutton | maintain | Buy → Buy | $6 | 30% |
| Jul 15, 2024 | EF Hutton | initiate | — → Buy | $6 | 30% |
| May 31, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $4 | 44% |
| Feb 14, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $4 | 44% |
| Aug 10, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $4 | 44% |
| Aug 1, 2023 | HC Wainwright & Co. | maintain | Buy → Buy | $4 | 44% |
| May 30, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $6 | 44% |
| Apr 3, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $6 | 44% |
| Mar 29, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $6 | 44% |
| Jan 18, 2022 | HC Wainwright & Co. | maintain | — → Buy | $6 | 44% |
| Nov 30, 2021 | Maxim Group | initiate | — → Buy | $4 | 42% |
| May 23, 2018 | HC Wainwright & Co. | initiate | — → Buy | $11 | 44% |
No cross-platform signals in the last 90 days